PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.580.04 (-0.71%)
5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.12%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
202.67%
Gross profit growth above 1.5x UPM.HE's 108.76%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
269.03%
EBIT growth above 1.5x UPM.HE's 53.27%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
269.03%
Operating income growth above 1.5x UPM.HE's 53.27%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
418.89%
Net income growth at 50-75% of UPM.HE's 811.54%. Martin Whitman would question fundamental disadvantages in expenses or demand.
414.96%
EPS growth at 50-75% of UPM.HE's 801.64%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
414.96%
Diluted EPS growth at 50-75% of UPM.HE's 801.64%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
1.11%
Share count expansion well above UPM.HE's 0.00%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.11%
Diluted share count expanding well above UPM.HE's 0.00%. Michael Burry would fear significant dilution to existing owners' stakes.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
153.49%
OCF growth above 1.5x UPM.HE's 18.63%. David Dodd would confirm a clear edge in underlying cash generation.
-74.15%
Negative FCF growth while UPM.HE is at 728.57%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-3.36%
Negative 10Y revenue/share CAGR while UPM.HE stands at 4.12%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
1.08%
5Y revenue/share CAGR similar to UPM.HE's 1.12%. Walter Schloss might see both companies benefiting from the same mid-term trends.
-4.19%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-91.08%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-89.59%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-92.29%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
37.31%
Net income/share CAGR 1.25-1.5x UPM.HE's 29.88%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
-12.49%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-64.04%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
108.37%
10Y equity/share CAGR above 1.5x UPM.HE's 41.35%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
36.57%
5Y equity/share CAGR above 1.5x UPM.HE's 10.80%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
7.77%
3Y equity/share CAGR 1.25-1.5x UPM.HE's 6.17%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
3.40%
Inventory growth well above UPM.HE's 6.26%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
2.00%
Similar asset growth to UPM.HE's 2.12%. Walter Schloss finds parallel expansions or investment rates.
1.73%
BV/share growth above 1.5x UPM.HE's 0.69%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-80.84%
We’re deleveraging while UPM.HE stands at 11.59%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We cut SG&A while UPM.HE invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.